For 25 years, RaySearch Laboratories has been creating value by advancing cancer treatment through software innovation. We have the ambition to keep you updated about our performance and other factors contributing to your assessment of RaySearch as an investment.
INVESTOR RELATIONS
Key figures (rolling 12m)
Latest press releases
From Image-Guided Ablation to Radiology Workstation: RaySearch Showcases Next-Level Innovations at RSNA 2025
Interim report third quarter 2025: Record high net sales and strong long-term performance
RaySearch receives additional RayStation order for advanced proton therapy at Stanford Health Care
The Share
Annual Report 2024
Subscribe
IR contact
- Carolina Haglund Strömlid
- Head of Investor Relations
- ir@raysearchlabs.com
- +46 (0)70 880 71 73